Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Vestnik of Saint Pet...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

Антибактериальная терапия в ферментативной фазе острого деструктивного панкреатита

Антибактериальная терапия в ферментативной фазе острого деструктивного панкреатита

Abstract

Proceeding from the results of the analysis of treating 260 patients with acute pancreatitis (AP), the causes predetermining development of purulent complications at the enzyme phase (the first 5 days as of the disease onset) include the following: 1) obvious paresis of gastrointestinal tract (in patients with severe pancreatitis, duration of the paresis in fact exceeds 4-fold these values in patients with light pancreatitis and 2-fold as compared with acute moderately severe pancreatitis. The amount of gastric content in the groups of patients with different grades of severity was essentially different and correlated with acute destructive pancreatitis (ADP) severity. At the 24-hour amount of gastric content 402±100,6 ml, purulent complications occurred in 11%, whereas at 963±256,5 ml — 38,3%). 2) The liver failure (at compensated liver failure, purulent complications subsequently developed in 20,2% of the patients, at subcompensated one — in 34,6%, at decompensated one — in 50%). 3) Laparotomic surgical interventions (in patients operated laparoscopically, purulent complications at delayed stages were diagnosed in 11,8% cases, whereas after the laparotomic interventions they developed over 2-fold more frequently: 25,8%). In their absence, as well as in the presence of a focus of infection (acute cholecystitis, cholangitis, pneumonia, etc.), the antibacterial therapy at an early period is inexpedient.

На основании анализа результатов лечения 260 больных острым панкреатитом установлено, что в ферментативной фазе (первые 5 суток от начала заболевания) основными причинами, определяющими в последующем развитие гнойных осложнений, являются: 1) выраженный парез желудочно-кишечного тракта (у больных с тяжелым панкреатитом продолжительность пареза практически в 4 раза превышала эти значения у больных с легким и в 2 раза — с острым панкреатитом средней тяжести. Объемы желудочного содержимого в группах больных с различными степенями тяжести ОП существенно отличались и коррелировали с тяжестью ОДП. При суточном обьеме желудочного содержимого 402±100,6 мл гнойные осложнения наблюдались у 11%, а при 963±256,5 мл в 38,3%);2) печеночная недостаточность (при компенсированной печеночной недостаточности гнойные осложнения в последующем развились у 20,2% больных, при субкомпенсированной — 34,6%, при декомпенсированной — 50%); 3) открытые оперативные вмешательства (у больных, оперированных лапароскопически, гнойные осложнения на поздних стадиях диагностированы в 11,8% случаев, в то время как после лапаротомных вмешательств более чем в 2 раза чаще — 25,8%). При их отсутствии, а также при отсутствии очага инфекции (острый холецистит, холангит, пневмония и др.) антибактериальная терапия в раннем периоде нецелесообразна.

Keywords

ОСТРЫЙ ДЕСТРУКТИВНЫЙ ПАНКРЕАТИТ, ФЕРМЕНТАТИВНАЯ ФАЗА, ПАРЕЗ КИШЕЧНИКА, ПЕЧЕНОЧНАЯ НЕДОСТАТОЧНОСТЬ, ОПЕРАТИВНЫЕ МЕТОДЫ ЛЕЧЕНИЯ, АНТИБИОТИКИ

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
gold
Related to Research communities